QQ客服 官方微博 反馈留言

	The 104-Week Efficacy and Safety of Telbivudine-Based Optimization Strategy in Chronic Hepatitis B Patients: A Randomized, Controlled Study
	Bai, Xuefan; Sun, Jian; Xie, Qing; Tan, Deming; Ning, Qin; Niu, Junqi; Fan, Rong; Chen, Shijun; Cheng, Jun; Yu, Yanyan
刊名	HEPATOLOGY
	2014
卷号	59期号:4
ISSN号	0270-9139
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3545364
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Bai, Xuefan,Sun, Jian,Xie, Qing,et al. The 104-Week Efficacy and Safety of Telbivudine-Based Optimization Strategy in Chronic Hepatitis B Patients: A Randomized, Controlled Study[J]. HEPATOLOGY,2014,59(4).
APA	Bai, Xuefan.,Sun, Jian.,Xie, Qing.,Tan, Deming.,Ning, Qin.,...&Hou, Jinlin.(2014).The 104-Week Efficacy and Safety of Telbivudine-Based Optimization Strategy in Chronic Hepatitis B Patients: A Randomized, Controlled Study.HEPATOLOGY,59(4).
MLA	Bai, Xuefan,et al."The 104-Week Efficacy and Safety of Telbivudine-Based Optimization Strategy in Chronic Hepatitis B Patients: A Randomized, Controlled Study".HEPATOLOGY 59.4(2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。